About Lucid Psycheceuticals
Lucid Psycheceuticals is a Healthcare company based in Toronto (Canada) founded in 2020 by Joseph L Romano, and was acquired by FSD Pharma in September 2021. Drugs for mental health disorders are manufactured and developed. The company has 5 employees. Its focus areas include Traditional Pharmaceuticals.
Company details
Lucid Psycheceuticals was founded in 2020 in Toronto, Canada, within the pharmaceutical sector. Focus is placed on the production of drugs aimed at treating various mental health disorders. Operations are centered on research, development, and manufacturing processes to address these conditions. Leadership includes co-founder Joseph L. Romano, with activities conducted primarily from the Canadian base to serve related healthcare needs.
- Headquarters Toronto, Canada
- Employees 5
- Founders Joseph L Romano
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website lucidpsycheceuticals.com
- Social LinkedIn
- Acquired by FSD Pharma (Sep 2021)
- Investors
- Employee Count5
- Acquired byFSD Pharma
(Sep 2021)
Investors in Lucid Psycheceuticals
Lucid Psycheceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cannabis company engaged in cultivation, processing, and manufacturing related activities | 2018 | fsdpharma.com | Cobourg, Canada |
Investor details for Lucid Psycheceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lucid Psycheceuticals
1 people are tracked at Lucid Psycheceuticals (1 in leadership); the tracked headcount is 5.
| Name | Role | Group |
|---|---|---|
Joseph L Romano | Co-Founder | Leadership |
Complete people profiles for Lucid Psycheceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lucid Psycheceuticals
2 dated milestones of Lucid Psycheceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Lucid Psycheceuticals is founded.
- Exit Acquired by FSD Pharma.
Web traffic of Lucid Psycheceuticals
The website of Lucid Psycheceuticals (lucidpsycheceuticals.com) receives about 1.3K visits a month.
- Monthly visits1.3K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lucid Psycheceuticals
Lucid Psycheceuticals was founded in 2020.
Lucid Psycheceuticals is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Lucid Psycheceuticals has 5 employees.
Lucid Psycheceuticals was founded in 2020 in Toronto, Canada, within the pharmaceutical sector. Focus is placed on the production of drugs aimed at treating various mental health disorders. Operations are centered on research, development, and manufacturing processes to address these conditions. Leadership includes co-founder Joseph L. Romano, with activities conducted primarily from the Canadian base to serve related healthcare needs.
Lucid Psycheceuticals has 1 investor. Key investors include FSD Pharma.
Yes. Lucid Psycheceuticals was acquired by FSD Pharma in September 2021.